US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
US6669951B2
(en)
*
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
US20040220100A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
DK2364734T3
(en)
|
2000-07-21 |
2017-10-30 |
Revance Therapeutics Inc |
Biological multicomponent transport systems
|
US20050059031A1
(en)
*
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
EP2085781B2
(en)
*
|
2000-10-06 |
2020-03-11 |
Life Technologies Corporation |
Transfectable micelles containing semiconductor nanocrystals
|
US7585834B2
(en)
*
|
2001-02-16 |
2009-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Transporters comprising spaced arginine moieties
|
US7491702B2
(en)
*
|
2001-04-18 |
2009-02-17 |
The Open University |
Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
|
US7622446B2
(en)
*
|
2001-04-18 |
2009-11-24 |
The Open University |
Polypeptides, derivatives and uses thereof
|
US20060173709A1
(en)
*
|
2005-01-31 |
2006-08-03 |
Traynor Daniel H |
Bodywash additive business methods
|
US7025952B1
(en)
|
2005-01-31 |
2006-04-11 |
Aquea Scientific Corporation |
Methods of preparation and use of bodywashes containing additives
|
US6998113B1
(en)
*
|
2005-01-31 |
2006-02-14 |
Aquea Scientific Corporation |
Bodywashes containing additives
|
US7037513B1
(en)
|
2005-01-31 |
2006-05-02 |
Aquea Scientific Corporation |
Bodywash additives
|
MXPA04005611A
(es)
*
|
2001-12-11 |
2005-04-19 |
Cellgate Inc |
Reactivos y conjugados de transporte de guanidinio.
|
ATE508188T1
(de)
|
2002-02-01 |
2011-05-15 |
Life Technologies Corp |
Oligonukleotid-zusammensetzungen mit verbesserter wirksamkeit
|
US20060009409A1
(en)
*
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP1572902B1
(en)
*
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
|
US20050222064A1
(en)
*
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
US20040029275A1
(en)
*
|
2002-08-10 |
2004-02-12 |
David Brown |
Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
|
EP1587908A4
(en)
*
|
2003-01-09 |
2008-02-20 |
Invitrogen Corp |
RELEASE AND ACTIVATION OF COMPLEX CELLS OF POLYPEPTIDES AND NUCLEIC ACIDS
|
US6969514B2
(en)
*
|
2003-02-05 |
2005-11-29 |
Soll David B |
Method for treating elevated intraocular pressure, including glaucoma
|
KR101064901B1
(ko)
*
|
2003-03-20 |
2011-09-16 |
나노캐리어 가부시키가이샤 |
난수용성 항암제와 신규 블록 공중합체를 포함하는 미셀조제물
|
CA2523672C
(en)
|
2003-04-29 |
2012-07-17 |
Avi Biopharma, Inc. |
Compositions for enhancing transport of molecules into cells
|
CA2524258C
(en)
|
2003-05-01 |
2012-08-07 |
Cornell Research Foundation, Inc. |
Carrier complexes comprising cationic peptides for delivering molecules to cells
|
WO2005072141A2
(en)
*
|
2004-01-16 |
2005-08-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptide inhibitors of rhoa signaling
|
PT2656859E
(pt)
*
|
2004-03-03 |
2016-02-24 |
Revance Therapeutics Inc |
Aplicação tópica e administração transdérmica de toxinas botulínicas
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
AU2005251676B2
(en)
|
2004-03-03 |
2011-09-29 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
KR100578732B1
(ko)
|
2004-03-05 |
2006-05-12 |
학교법인 포항공과대학교 |
분자 수송체로서의 이노시톨 유도체 및 이의 제조방법
|
US20050288246A1
(en)
|
2004-05-24 |
2005-12-29 |
Iversen Patrick L |
Peptide conjugated, inosine-substituted antisense oligomer compound and method
|
GB0413613D0
(en)
*
|
2004-06-17 |
2004-07-21 |
Univ London |
Small molecule carriers
|
CN101023119B
(zh)
|
2004-09-22 |
2010-05-05 |
日本化药株式会社 |
新型嵌段共聚物,胶束制剂以及含胶束制剂为活性组分的抗癌剂
|
US7442682B2
(en)
*
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
US7001592B1
(en)
|
2005-01-31 |
2006-02-21 |
Aquea Scientific Corporation |
Sunscreen compositions and methods of use
|
US9180081B2
(en)
|
2005-03-03 |
2015-11-10 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
ATE507236T1
(de)
|
2005-03-03 |
2011-05-15 |
Revance Therapeutics Inc |
Zusammensetzungen und methoden zur topischen anwendung und zur transdermalen verabreichung eines oligopeptids
|
US20080112904A1
(en)
*
|
2005-03-08 |
2008-05-15 |
Daniel Henry Traynor |
Sunscreen Compositions And Methods Of Use
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
WO2007038169A2
(en)
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Multi-valent guanidinium compounds for molecular translocation across cellular membranes and epithelial tissues
|
WO2007038172A2
(en)
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Guanidinium carriers
|
US7700565B2
(en)
|
2005-09-23 |
2010-04-20 |
Nitto Denko Corporation |
Peptide nucleic acid based guanidinium compounds
|
US8568740B2
(en)
*
|
2005-11-17 |
2013-10-29 |
Revance Therapeutics, Inc. |
Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
|
CA2638915A1
(en)
*
|
2006-02-10 |
2007-08-23 |
The Regents Of The University Of California |
Transducible delivery of sirna by dsrna binding domain fusions to ptd/cpps
|
WO2008069824A2
(en)
*
|
2006-02-27 |
2008-06-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for transport of molecules with enhanced release properties across biological barriers
|
US7696165B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
US7696166B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
JP5249016B2
(ja)
|
2006-03-28 |
2013-07-31 |
日本化薬株式会社 |
タキサン類の高分子結合体
|
KR20090009241A
(ko)
*
|
2006-05-18 |
2009-01-22 |
니폰 가야꾸 가부시끼가이샤 |
포도필로톡신류의 고분자 결합체
|
JP2010504929A
(ja)
|
2006-09-27 |
2010-02-18 |
ボッティ,パオロ |
生体系への送達を高める手段及び方法
|
US20090239782A1
(en)
*
|
2006-10-03 |
2009-09-24 |
Masaharu Nakamura |
High-molecular weight conjugate of resorcinol derivatives
|
EP2080779B1
(en)
|
2006-11-06 |
2016-05-18 |
Nippon Kayaku Kabushiki Kaisha |
Polymeric derivative of nucleic acid metabolic antagonist
|
EP2090607B1
(en)
|
2006-11-08 |
2015-05-20 |
Nippon Kayaku Kabushiki Kaisha |
Polymeric derivative of nucleic acid metabolic antagonist
|
US20100093639A1
(en)
*
|
2006-12-29 |
2010-04-15 |
Revance Therapeutics, Inc. |
Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides
|
MX2009007068A
(es)
*
|
2006-12-29 |
2009-07-10 |
Revance Therapeutics Inc |
Composiciones y metodos de aplicacion topica y suministro transdermico de toxinas botulinicas estabilizadas con fragmentos de polipeptido provenientes de hiv-tat.
|
WO2008144734A1
(en)
*
|
2007-05-21 |
2008-11-27 |
Aquea Scientific Corporation |
Highly charged microcapsules
|
ES2694726T3
(es)
*
|
2007-06-29 |
2018-12-26 |
Sarepta Therapeutics, Inc. |
Conjugados peptídicos específicos de tejido y métodos
|
US20100016215A1
(en)
*
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
ES2805225T3
(es)
|
2007-07-26 |
2021-02-11 |
Revance Therapeutics Inc |
Péptidos antimicrobianos y composiciones de los mismos
|
JP5349318B2
(ja)
*
|
2007-09-28 |
2013-11-20 |
日本化薬株式会社 |
ステロイド類の高分子結合体
|
US7935816B2
(en)
*
|
2007-10-25 |
2011-05-03 |
Gene Tools, Llc |
Molecular transporter compositions comprising dendrimeric oligoguanidine with a triazine core that facilitate delivery into cells in vivo
|
US20110160146A1
(en)
*
|
2008-02-07 |
2011-06-30 |
National Institute of Health (NIH) |
Conjungation of Small Molecules to Octaarginine Transporters for Overcoming Multi-Drug Resistance
|
EP2258397B1
(en)
*
|
2008-03-18 |
2017-10-11 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of physiologically active substance
|
WO2009136572A1
(ja)
|
2008-05-08 |
2009-11-12 |
日本化薬株式会社 |
葉酸若しくは葉酸誘導体の高分子結合体
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
WO2010072228A1
(en)
*
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
ES2347119B2
(es)
*
|
2009-04-22 |
2011-04-28 |
Universidad De Santiago De Compostela |
Nanocapsulas de poliarginina.
|
EP2431403B1
(en)
|
2009-05-15 |
2016-09-28 |
Nipponkayaku Kabushikikaisha |
Polymer conjugate of bioactive substance having hydroxy group
|
US20110269665A1
(en)
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
JP2013511275A
(ja)
|
2009-11-18 |
2013-04-04 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
組織再生を誘導する方法
|
NO2504357T3
(es)
*
|
2009-11-23 |
2017-12-30 |
|
|
AU2011248625B2
(en)
|
2010-04-26 |
2017-01-05 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
|
JP6294074B2
(ja)
|
2010-04-27 |
2018-03-14 |
エータイアー ファーマ, インコーポレイテッド |
イソロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
WO2011139853A2
(en)
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
US9068177B2
(en)
|
2010-04-29 |
2015-06-30 |
Atyr Pharma, Inc |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
|
CA2797393C
(en)
|
2010-04-29 |
2020-03-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
CA2797374C
(en)
|
2010-04-29 |
2021-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
CA2797978C
(en)
|
2010-05-03 |
2019-12-03 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
CN103096925A
(zh)
|
2010-05-03 |
2013-05-08 |
Atyr医药公司 |
与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CN103096912A
(zh)
|
2010-05-03 |
2013-05-08 |
Atyr医药公司 |
与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CN102985103A
(zh)
|
2010-05-04 |
2013-03-20 |
Atyr医药公司 |
与p38多-tRNA合成酶复合物相关的治疗、诊断和抗体组合物的创新发现
|
JP6396656B2
(ja)
|
2010-05-14 |
2018-09-26 |
エータイアー ファーマ, インコーポレイテッド |
フェニルアラニルβtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
US8962560B2
(en)
|
2010-06-01 |
2015-02-24 |
Atyr Pharma Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
CA2804416C
(en)
|
2010-07-12 |
2020-04-28 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
AU2011293294B2
(en)
|
2010-08-25 |
2016-03-24 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
|
CA2807036C
(en)
|
2010-10-14 |
2018-01-16 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
JP5856069B2
(ja)
|
2010-11-17 |
2016-02-09 |
日本化薬株式会社 |
新規なシチジン系代謝拮抗剤の高分子誘導体
|
WO2012066376A1
(en)
*
|
2010-11-18 |
2012-05-24 |
Centre National De La Recherche Scientifique - Cnrs - |
Inhibitors of apoptosis and uses thereof
|
US9161948B2
(en)
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
KR102339196B1
(ko)
|
2011-05-05 |
2021-12-15 |
사렙타 쎄러퓨틱스, 인코퍼레이티드 |
펩타이드 올리고뉴클레오타이드 접합체
|
RU2623426C2
(ru)
|
2011-09-11 |
2017-06-26 |
Ниппон Каяку Кабусики Кайся |
Способ получения блок-сополимера
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
US20150064141A1
(en)
|
2012-04-05 |
2015-03-05 |
The Regents Of The University Of California |
Regenerative sera cells and mesenchymal stem cells
|
US9816066B2
(en)
|
2012-04-24 |
2017-11-14 |
The Regents Of The University Of California |
Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters
|
EA038924B1
(ru)
|
2012-05-25 |
2021-11-10 |
Те Риджентс Оф Те Юниверсити Оф Калифорния |
Способы и композиции рнк-специфической модификации днк-мишени и рнк-специфической модуляции транскрипции
|
EP2885313A4
(en)
|
2012-08-20 |
2016-03-09 |
Univ California |
POLYNUCLEOTIDES WITH BIOREVERSIBLE GROUPS
|
MX370929B
(es)
|
2012-10-28 |
2020-01-08 |
Revance Therapeutics Inc |
Composiciones y usos de las mismas para el tratamiento seguro de la rinitis.
|
US11690793B2
(en)
|
2012-11-06 |
2023-07-04 |
Colabs Int'l Corp. |
Composition containing a cellulose derived capsule with a sunscreen
|
US11707421B2
(en)
|
2012-11-06 |
2023-07-25 |
Colabs Int'l Corp. |
Compositions containing a flexible derived capsule with an active agent
|
US10322301B2
(en)
|
2012-11-06 |
2019-06-18 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11724134B2
(en)
|
2012-11-06 |
2023-08-15 |
CoLabs International Corporation |
Compositions containing a cellulose derived capsule with a sunscreen active agent
|
US11491088B2
(en)
|
2012-11-06 |
2022-11-08 |
CoLabs International Corporation |
Compositions containing a capsule with a moisturizing agent
|
JP2015536985A
(ja)
|
2012-11-06 |
2015-12-24 |
コラブス インターナショナル コーポレーション |
日焼け止めを含むセルロース由来カプセル含有組成物
|
US9353150B2
(en)
|
2012-12-04 |
2016-05-31 |
Massachusetts Institute Of Technology |
Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
|
CN105377867B
(zh)
|
2013-05-03 |
2019-11-12 |
加利福尼亚大学董事会 |
I型干扰素的环状二核苷酸诱导
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
EA201501080A1
(ru)
|
2013-06-26 |
2016-07-29 |
Ксижен Инфлемейшн Лтд. |
Новое применение обладающих способностью проникать в клетку пептидных ингибиторов пути трансдукции сигнала jnk для лечения различных заболеваний
|
WO2015197097A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
EP3690032A1
(en)
|
2013-09-20 |
2020-08-05 |
Lonza Ltd. |
Methods for nuclear reprogramming of cells
|
WO2015071474A2
(en)
|
2013-11-18 |
2015-05-21 |
Crispr Therapeutics Ag |
Crispr-cas system materials and methods
|
EP3080266B1
(en)
|
2013-12-12 |
2021-02-03 |
The Regents of The University of California |
Methods and compositions for modifying a single stranded target nucleic acid
|
RU2549908C1
(ru)
*
|
2014-03-12 |
2015-05-10 |
Общество С Ограниченной Ответственностью "Саентифик Фьючер Менеджмент" |
Биодеградируемые аргининсодержащие полимеры
|
PT3149025T
(pt)
|
2014-05-21 |
2019-08-01 |
Entrada Therapeutics Inc |
Peptídeos penetrantes de células e métodos de fabrico e utilização dos mesmos
|
US10815276B2
(en)
|
2014-05-21 |
2020-10-27 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
US10456443B2
(en)
|
2014-08-27 |
2019-10-29 |
Ohio State Innovation Foundation |
Peptidyl calcineurin inhibitors
|
WO2016123380A1
(en)
|
2015-01-29 |
2016-08-04 |
Leuvas Therapeutics |
Modulators of protein tyrosine phosphatase and uses thereof
|
US10377818B2
(en)
|
2015-01-30 |
2019-08-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of treating glioma
|
US10392607B2
(en)
|
2015-06-03 |
2019-08-27 |
The Regents Of The University Of California |
Cas9 variants and methods of use thereof
|
US11020417B2
(en)
|
2015-06-04 |
2021-06-01 |
Sarepta Therapeutics, Inc |
Methods and compounds for treatment of lymphocyte-related diseases and conditions
|
CA2998287A1
(en)
|
2015-09-24 |
2017-04-20 |
Crispr Therapeutics Ag |
Novel family of rna-programmable endonucleases and their uses in genome editing and other applications
|
EA201891619A1
(ru)
|
2016-01-11 |
2019-02-28 |
Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити |
Химерные белки и способы регулирования экспрессии генов
|
JP7012645B2
(ja)
|
2016-01-11 |
2022-01-28 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
キメラタンパク質および免疫治療の方法
|
WO2017143071A1
(en)
|
2016-02-18 |
2017-08-24 |
The Regents Of The University Of California |
Methods and compositions for gene editing in stem cells
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
BR112019012647A2
(pt)
|
2016-12-19 |
2019-11-19 |
Sarepta Therapeutics Inc |
conjugados de oligômero de salto de éxon para distrofia muscular
|
US11932650B2
(en)
|
2017-05-11 |
2024-03-19 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
CA3084825A1
(en)
|
2017-12-14 |
2019-06-20 |
Crispr Therapeutics Ag |
Novel rna-programmable endonuclease systems and their use in genome editing and other applications
|
EP3749365A4
(en)
|
2018-01-29 |
2022-01-12 |
Ohio State Innovation Foundation |
PEPTIDY INHIBITORS OF THE CALCINEURIN-NFAT INTERACTION
|
EP3755351A4
(en)
|
2018-02-22 |
2021-11-24 |
Entrada Therapeutics, Inc. |
COMPOSITIONS AND TREATMENT METHODS FOR MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY
|
AU2019239957A1
(en)
|
2018-03-19 |
2020-09-10 |
Bayer Healthcare Llc |
Novel RNA-programmable endonuclease systems and uses thereof
|
KR102167755B1
(ko)
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
EP3813786A4
(en)
|
2018-06-27 |
2022-06-29 |
Colabs International Corporation |
Compositions comprising silicon dioxide-based particles including one or more agents
|
MX2021010559A
(es)
|
2019-03-07 |
2021-12-15 |
Univ California |
Polipéptidos efectores de crispr-cas y métodos de uso de estos.
|
US20220145274A1
(en)
|
2019-03-12 |
2022-05-12 |
Crispr Therapeutics Ag |
Novel high fidelity rna-programmable endonuclease systems and uses thereof
|
WO2020247054A1
(en)
|
2019-06-05 |
2020-12-10 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
KR20230135586A
(ko)
|
2021-01-24 |
2023-09-25 |
마이클 데이비드 포레스트 |
Atp 합성효소 억제제 - 미용 및 치료 용도
|
IL308896A
(en)
|
2021-06-11 |
2024-01-01 |
Bayer Ag |
Programmable type V RNA endoclase systems
|
EP4101928A1
(en)
|
2021-06-11 |
2022-12-14 |
Bayer AG |
Type v rna programmable endonuclease systems
|
WO2023023276A1
(en)
*
|
2021-08-19 |
2023-02-23 |
N1 Life, Inc. |
Taxol conjugate compounds, pharmaceutical compositions comprising the same, and methods for their use
|
TW202317752A
(zh)
|
2021-09-01 |
2023-05-01 |
美商德諾沃股份有限公司 |
由非毛囊幹細胞至非聽覺誘導毛囊幹細胞的轉分化
|
EP4144841A1
(en)
|
2021-09-07 |
2023-03-08 |
Bayer AG |
Novel small rna programmable endonuclease systems with impoved pam specificity and uses thereof
|
WO2023070026A1
(en)
|
2021-10-20 |
2023-04-27 |
Dnovo Inc. |
Transdifferentiation of non-dermal papilla cells to dermal papilla cells
|
WO2023118068A1
(en)
|
2021-12-23 |
2023-06-29 |
Bayer Aktiengesellschaft |
Novel small type v rna programmable endonuclease systems
|
WO2023237587A1
(en)
|
2022-06-10 |
2023-12-14 |
Bayer Aktiengesellschaft |
Novel small type v rna programmable endonuclease systems
|